Patents by Inventor Soren Halskov

Soren Halskov has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS
    Publication number: 20240016753
    Abstract: The invention provides a pharmaceutical composition comprising activated carbon particles, for oral administration. The pharmaceutical composition may be for (use in) the treatment of gastrointestinal fistula.
    Type: Application
    Filed: June 12, 2023
    Publication date: January 18, 2024
    Applicant: FERRING B.V.
    Inventor: Soren Halskov
  • Pharmaceutical compositions comprising activated carbon
    Patent number: 11712422
    Abstract: The invention provides a pharmaceutical composition comprising activated carbon particles, for oral administration. The pharmaceutical composition may be for (use in) the treatment of gastrointestinal fistula.
    Type: Grant
    Filed: December 10, 2020
    Date of Patent: August 1, 2023
    Assignee: Ferring B.V.
    Inventor: Soren Halskov
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20210196647
    Abstract: The invention provides a pharmaceutical composition comprising activated carbon particles, for oral administration. The pharmaceutical composition may be for (use in) the treatment of gastrointestinal fistula.
    Type: Application
    Filed: December 10, 2020
    Publication date: July 1, 2021
    Applicant: FERRING B.V.
    Inventor: Soren Halskov
  • Composition for the treatment of fistula
    Patent number: 10617644
    Abstract: A composition for use in the treatment of fistula, the composition comprising activated carbon.
    Type: Grant
    Filed: August 30, 2017
    Date of Patent: April 14, 2020
    Assignee: FERRING B.V.
    Inventors: Soren Halskov, Mats Ekelund
  • Pharmaceutical activated carbon composition
    Patent number: 10449158
    Abstract: The invention provides a pharmaceutical composition comprising activated carbon particles, for oral administration. The pharmaceutical composition may be for (use in) the treatment of gastrointestinal fistula.
    Type: Grant
    Filed: September 20, 2013
    Date of Patent: October 22, 2019
    Assignee: FERRING B.V.
    Inventor: Soren Halskov
  • Composition for the Treatment of Fistula
    Publication number: 20180207098
    Abstract: A composition for use in the treatment of fistula, the composition comprising activated carbon.
    Type: Application
    Filed: April 11, 2018
    Publication date: July 26, 2018
    Inventors: Soren Halskov, Mats Ekelund
  • Composition for the treatment of fistula
    Patent number: 9763882
    Abstract: A composition for use in the treatment of fistula, the composition comprising activated carbon.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: September 19, 2017
    Assignee: Ferring BV
    Inventors: Søren Halskov, Mats Ekelund
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20150245999
    Abstract: The invention provides a pharmaceutical composition comprising activated carbon particles, for oral administration. The pharmaceutical composition may be for (use in) the treatment of gastrointestinal fistula.
    Type: Application
    Filed: September 20, 2013
    Publication date: September 3, 2015
    Applicant: FERRING B.V.
    Inventor: Soren Halskov
  • Composition for the Treatment of Fistula
    Publication number: 20140288491
    Abstract: A composition for use in the treatment of fistula, the composition comprising activated carbon.
    Type: Application
    Filed: October 3, 2012
    Publication date: September 25, 2014
    Applicant: FERRING B.V.
    Inventors: Søren Halskov, Mats Ekelund
  • Device and method for delivering a dose of medicament comprising activated carbon particles
    Publication number: 20140243794
    Abstract: A device for delivering a dose of medicament comprising activated carbon particles to a patient's rectal cavity has a rectally-insertable cannula. The cannula has a proximal opening, a distal opening and a cavity defined between the proximal and distal openings for containing the medicament. An openable closure spans the proximal opening of the cannula. An actuation means is arranged to drive a volume of fluid, for example water or air, through the cannula cavity to flush the dose of medicament through the distal opening of the cannula.
    Type: Application
    Filed: October 3, 2012
    Publication date: August 28, 2014
    Applicant: FERRING B.V.
    Inventors: Søren Halskov, Lars Svensson
  • PHARMACEUTICAL COMPOSITION
    Publication number: 20140107197
    Abstract: A pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate.
    Type: Application
    Filed: December 20, 2013
    Publication date: April 17, 2014
    Applicant: Ferring International Center S.A.
    Inventors: Klaus Jensen, Soren Halskov, Henning Lund
  • Pharmaceutical composition
    Patent number: 8637570
    Abstract: A pharmaceutical composition comprising a docusate; an osmotic laxative; and a benzoate.
    Type: Grant
    Filed: December 5, 2008
    Date of Patent: January 28, 2014
    Assignee: Ferring International Center S.A.
    Inventors: Klaus Jensen, Soren Halskov, Henning Lund
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
    Patent number: 5041431
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicyclic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: August 20, 1991
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
    Patent number: 5013727
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: May 7, 1991
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
    Patent number: 4980173
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: December 25, 1990
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
    Patent number: 4960765
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: June 26, 1989
    Date of Patent: October 2, 1990
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
    Patent number: 4880794
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: June 8, 1987
    Date of Patent: November 14, 1989
    Inventor: Soren Halskov
  • Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
    Patent number: 4664256
    Abstract: A packaged enema solution or suspension consisting essentially of an effective amount of 5-ASA or a pharmaceutically acceptable salt or ester thereof, a chelating agent, an antioxidant and a buffer, the solution or suspension having a pH value of from 4 to 7 and being contained in a plastic bottle under an inert gas, the plastic bottle being packaged in a diffusion-tight light-impervious package in the same inert gas as is present in the bottle.
    Type: Grant
    Filed: October 2, 1985
    Date of Patent: May 12, 1987
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
    Patent number: 4496553
    Abstract: A pharmaceutical composition containing as active ingredient 5-aminosalicyclic acid or a pharmaceutically acceptable salt or ester thereof allow the treatment of colitis ulcerosa or Crohn's disease by oral administration. A particular slow-release tablet formation and its preparation is disclosed.
    Type: Grant
    Filed: November 28, 1983
    Date of Patent: January 29, 1985
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov
  • Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
    Patent number: RE33239
    Abstract: A packaged enema solution or suspension consisting essentially of an effective amount of 5-ASA or a pharmaceutically acceptable salt or ester thereof, a chelating agent, in antioxidant and a buffer, the solution or suspension having a pH value of from 4 to 7 and being contained in a plastic bottle under an inert gas, the plastic bottle being packaged in a diffusion-tight light-impervious package in the same inert gas as is present in the bottle.
    Type: Grant
    Filed: May 12, 1989
    Date of Patent: June 26, 1990
    Assignee: Farmaceutisk Laboratorium Ferring A/S
    Inventor: Soren Halskov